/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Pathological assessment of osimertinib-associated cardiotoxicity in EGFR-mutated non-small cell lung cancer patients
Event: ESC Congress 2020
Topic: Cardiotoxicity of Drugs and Other Therapies
Session: Chronic Heart Failure ePosters
ESC 365 is supported by
